Skip to content

Khaled Abdelrahman, MD

NPI 1780210054ActiveIndividual· Internal Medicine· Boston, MA

Internal Medicine (MD) in Boston, Massachusetts, licensed in MA, with an NPI issued in March 2020. Part D covered 172 prescriptions written in 2024, 76% of them generic. Boston Scientific Corporation was the largest of 2 companies reporting payments in 2025, $4,206 in all, mostly travel and lodging.

Overview

NPI1780210054
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 19, 2020
Last updated in NPPESJun 14, 2021
Certified by providerJun 14, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X289015MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (MA)

Part D prescriptions in 2024

Prescriptions (claims)172 · 401 30-day fills
Patients59
Total drug cost$42,028
Generic share76% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$4,206 · 23 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Boston Scientific Corporation$2,5598
Biosense Webster, Inc.$1,64715

What the 2025 payments were for

  • Travel and Lodging$2,325 · 9 payments
  • Food and Beverage$1,882 · 14 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Boston

All Internal Medicine providers in Massachusetts →